‘In 2003, RNTCP had eight lines in the guidelines that related to TB in children’
After years of neglect by the WorldPu Health Organisation and almost all the national tuberculosis programmes [NTP] across the world,
Read MoreDay: January 14, 2016
Clinical trials on child-friendly bedaquiline MDR-TB drug for children initiated
“Before the BPCA [Best Pharmaceuticals for Children Act] and the PREA [Paediatric Research Equity Act] became law, more than 80
Read More‘Nuances of childhood TB are never taught in medical schools’
If diagnosing tuberculosis in children, particularly those aged under five years, is fraught with problems, health-care workers at different levels
Read MoreChild-friendly, first-line TB combination drugs will be available in 2016: Dr. Mel Spigelman
Dr. Mel Spigelman, President and Chief Executive Officer of the Global Alliance for TB Drug Development (TB Alliance) is regarded
Read MoreEditorial: New bird flu strains
If the bird flu strain H7N9 emerged in China in March this year, causing infections in about 134 people and
Read MoreTB in children
Childhood TB has been neglected for decades, but in the past few years the WHO has begun to realise
Read MoreSecond-line TB drugs: ‘It is more difficult to assess adverse effects in children’
Prof. H. Simon Schaaf, a clinical researcher from the Department of Paediatrics and Child Health, Faculty of Health Sciences,
Read More‘Children metabolise TB drugs much faster than adults’
Dr. Peter R. Donald, Emeritus Professor in the Department of Paediatrics and Child Health of the Faculty of Health
Read MoreMalnourished children in India below three years are underdosed for first-line TB drugs
“The ultimate goal of evidence-based drug treatment is to produce a desired pharmacological response in a predictable manner and also
Read More‘Sentinel Project provides guidance on preventive treatment for children with MDR-TB infection’
Mercedes C Becerra is an Associate Professor in the Department of Global Health and Social Medicine at Harvard Medical School.
Read MoreSentinel Project gives a fillip to managing MDR-TB in children
The Sentinel Project on Pediatric Drug-Resistant Tuberculosis is a collective power of a global partnership by experts and others
Read More‘In 80-90 %, TB bacilli in children same as in MDR-TB index case’
Prof. H. Simon Schaaf, a clinical researcher from the Department of Paediatrics and Child Health, Faculty of Health Sciences,
Read More‘Very few children in India are diagnosed and treated for MDR-TB’
“A child with TB [is] as likely as an adult with TB to have MDR-TB [multi-drug resistant TB],” notes
Read More